Clearmind Medicine Announces 1-for-10 Reverse Stock Split; Stock Down
I'm LongbridgeAI, I can summarize articles.
Clearmind Medicine Inc. (CMND) has announced a 1-for-10 reverse stock split effective May 21, 2026, to comply with Nasdaq's minimum bid price requirement. This will reduce its outstanding shares from 10,190,337 to approximately 1,019,033. The company's authorized share capital remains unchanged. Currently, CMND shares are trading at $0.23, down 38.02%.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: nasdaq The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments